[18F]FDG-PET CT for the evaluation of native valve endocarditis

J Nucl Cardiol. 2022 Feb;29(1):158-165. doi: 10.1007/s12350-020-02092-6. Epub 2020 Mar 16.

Abstract

Background: We examined the use of [18F]FDG-PET/CT for the diagnosis of native valve endocarditis (NVE).

Methods: PET/CT images in patients with suspected NVE were retrospectively reviewed independently by two experienced physicians blinded to all clinical information. The gold standard consisted of surgical findings, when available, or the modified Duke criteria.

Results: Fifty four subjects were included, 31 (57%) with a diagnosis of NVE. [18F]FDG-PET/CT correctly identified 21/31 (67.7%) subjects, yielding a sensitivity and specificity of 68% (95% CI 49-83%) and 100% (95% CI 85-100%), respectively. The sensitivity and specificity of the modified Duke criteria were 48% and 74%, respectively. Positive and negative predictive values of PET were 100% (95% CI 84-100%) and 70% (95% CI 51-84%), respectively. Modifying the Duke criteria to include [18F]FDG-PET positivity as a major criterion increased sensitivity to 77% without affecting specificity and led to the correct reclassification of 8/18 (44.4%) subjects from Possible IE to Definite IE.

Conclusion: The addition of a positive [18F]FDG-PET/CT as a major criterion in the modified Duke Criteria improved performance of the criteria for the diagnosis of NVE, particularly in those subjects with Possible IE.

Keywords: FDG; Infective endocarditis; Native valve; Positron emission tomography; fluorodeoxyglucose.

MeSH terms

  • Endocarditis* / diagnostic imaging
  • Fluorodeoxyglucose F18*
  • Humans
  • Positron Emission Tomography Computed Tomography / methods
  • Radiopharmaceuticals
  • Retrospective Studies

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18